It’s Official Medicine Now: Women Can Get Prostate Cancer Too! By Mrs Vera West
Now we know; trans women can get prostate cancer, just like men. There you go. And, it makes sense too, as people, born as males, were born with prostates, and if not removed, cancer is always possible. And if trans men can have babies, we should not be surprised. We should not be surprised about anything anymore.
https://jamanetwork.com/journals/jama/fullarticle/2804566
“Transgender women retain their prostate even after gender-affirmation surgery and thus remain at risk of prostate cancer. Studies to date are limited to case reports.1 We describe a large case series of transgender women with prostate cancer within the Veterans Affairs (VA) health system.
After Durham VA institutional review board approval with a waiver of informed consent, VA records for all adults with an International Classification of Diseases code for prostate cancer and at least 1 code for transgender identity at any time from January 2000 to November 2022 were queried. Detailed chart review was performed to confirm transgender identity and prostate cancer diagnosis. The number of cases per year was approximated using previous estimates of the median year of transgender identity entry in VA records (2011), corresponding to approximately 11 years of follow-up (2011-2022).2 Data from community clinicians were included if available in VA notes. Data at diagnosis were collected, including gender-affirming hormone therapies used, prostate-specific antigen (PSA), PSA density (measure of prostate cancer aggressiveness [lower risk, <0.15 ng/mL/g]), bilateral orchiectomy status, biopsy grade group (grades 1-5, with 5 being most severe), and clinical stage (T1-T4, with T4 being most advanced; eMethods in Supplement 1). Because estrogen, which lowers testosterone and suppresses prostate cancer,3 was the most common feminization therapy, patients were grouped by never used estrogen, formerly used estrogen but stopped prior to prostate cancer diagnosis, or actively used estrogen at diagnosis. Due to limited sample sizes, analyses were only descriptive.”
Comments